George D. Behrakis


  • Investor, former biopharmaceutical executive, philanthropist
  • Former pharmacist and pharmaceutical innovator well known in the industry for his contributions to the successful development and commercial launch of Tylenol® while at Johnson & Johnson
  • Founder and CEO of two successful companies – Dooner Laboratories and Muro Pharmaceuticals – where he led the research, regulatory approval, commercialization, marketing, and global manufacturing of asthma, allergy, ophthalmic nasal, and oral inhaled prescription therapies, ultimately selling both, creating significant shareholder value and advances for patients
  • His large-scale philanthropic efforts helped fund the creation of Northeastern University’s College of Health Sciences, the Behrakis Health Sciences Center, and launch a critical national anti-smoking initiative in Greece in collaboration with Harvard University
  • Former Vice Chair of the Board of Northeastern University, and former Board member of Brigham and Women’s Hospital and Tufts Medical Center
  • Currently serves as a board member of the Boston Symphony Orchestra and is a “guardian” of the Museum of Fine Arts in Boston; the George D. and Margo Behrakis Art of the Ancient World Wing is so named because of the family’s long and deep relationship with the museum